4
Changes in Ownership
SpyGlass Pharma, Inc. Filed Acc 0001193125-26-046671
10% owner bought 937,500 shares at $16.00 ($15,000,000)
- 10% owner acquired 5,097,538 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
New Enterprise Associates 17, L.P. · 10% owner
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-09 | Conversion : show line 1 in the form | +1,619,240 | 1,619,240 | D | ||
| 2026-02-09 | Conversion : show line 2 in the form | +1,370,168 | 2,989,408 | D | ||
| 2026-02-09 | Conversion : show line 3 in the form | +1,370,168 | 4,359,576 | D | ||
| 2026-02-09 | Conversion : show line 4 in the form | +737,962 | 5,097,538 | D | ||
| 2026-02-09 | Purchase : show line 5 in the form | +937,500 | $16.00 | $15,000,000 | 6,035,038 | D |
| Open-market purchases · 937,500 sh · avg $16.00 · $15,000,000 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-09 | Conversion : show line 6 in the form Series B Preferred Stock | −1,619,240 | 0 | D |
| 2026-02-09 | Conversion : show line 7 in the form Series C-1 Preferred Stock | −1,370,168 | 0 | D |
| 2026-02-09 | Conversion : show line 8 in the form Series C-2 Preferred Stock | −1,370,168 | 0 | D |
| 2026-02-09 | Conversion : show line 9 in the form Series D Preferred Stock | −737,962 | 0 | D |
Loading xslF345X05/ownership.xml…